Form 4 Larimar Therapeutics, For: May 13 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) May 15, 2025 07:44PM
Form 4 Larimar Therapeutics, For: May 29 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Jun 3, 2024 06:31PM
Form 4 Larimar Therapeutics, For: May 09 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) May 11, 2023 06:32PM
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results Mar 14, 2023 07:00AM
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results Nov 10, 2022 07:00AM


Sep 20, 2022 08:32PM Form 4 Larimar Therapeutics, For: Sep 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Sep 16, 2022 01:00PM Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
Sep 14, 2022 07:04AM Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock
Sep 14, 2022 07:04AM Larimar Therapeutics Announces $70 Million Underwritten Offering
May 11, 2022 05:43PM Form 4 Larimar Therapeutics, For: May 10 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
May 21, 2021 09:19AM Larimar Therapeutics (LRMR) Announces $95 Million Private Placement Financing of Common Stock, Warrants
May 21, 2021 09:18AM Larimar Therapeutics Announces $95 Million Private Placement Financing
May 17, 2021 05:17PM Form 4 Larimar Therapeutics, For: May 12 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics